• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

141
19
13
13
11

COUNTRY

5
4
4
4
3

PRICE

6
90
123
501

PUBLISHED

2
13
121
501

PRODUCT TYPE

491
5
2
1

Immune Disorders

(501 Products)

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015 Summary This, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s...

January 2015
FROM

House Dust Mite Allergy - Pipeline Review, H1 2015

House Dust Mite Allergy - Pipeline Review, H1 2015 Summary This, ‘House Dust Mite Allergy - Pipeline Review, H1 2015’, provides an overview of the House Dust Mite Allergy’s therapeutic pipeline. This...

January 2015
FROM

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

Chronic Plaque Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline. This...

January 2015
FROM

Birch Pollen Allergy - Pipeline Review, H1 2015

Birch Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Birch Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Birch Pollen Allergy’s therapeutic pipeline. This report...

January 2015
FROM

Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015 Summary This, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

January 2015
FROM
Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape - Product Thumbnail Image

Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Summary "Gene Therapy Immunology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles...

January 2015
FROM

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity...

December 2014
FROM

Orencia (abatacept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Orencia (abatacept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints...

December 2014
FROM

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

December 2014
FROM

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the...

December 2014
FROM

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints....

December 2014
FROM

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints....

December 2014
FROM

Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

PharmaPoint: Rheumatoid Arthritis - Current and Future Players

PharmaPoint: Rheumatoid Arthritis - Current and Future Players Summary The publisher has released its pharma report, “PharmaPoint: Rheumatoid Arthritis - Current and Future Players”. The report is...

December 2014
FROM

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

December 2014
FROM

RAVAX (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

RAVAX (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects...

December 2014
FROM

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints...

December 2014
FROM

Peficitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Peficitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints...

December 2014
FROM
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare